TY - JOUR
T1 - Binocular Visual Function With Staged Implantation of Diffractive Multifocal Intraocular Lenses With Three Add Powers
AU - Bissen-Miyajima, Hiroko
AU - Ota, Yuka
AU - Nakamura, Kunihiko
AU - Hirasawa, Manabu
AU - Minami, Keiichiro
N1 - Funding Information:
Funding/Support: The study was supported by Johnson & Johnson Surgical Vision (Santa Ana, CA). Financial Disclosures: Hiroko Bissen-Miyajima: Alcon (consulting, lectures); Johnson & Johnson Surgical Vision (consulting, lectures); Zeiss (consulting); Santen (consulting, lectures); HOYA (consulting, lectures); Keiichiro Minami: AMO Japan K.K, Japan (consulting); Alcon Japan Ltd, Japan (consulting); Tomey Corporation, Japan (patent). The following authors have no financial disclosures: Yuka Ota, Kunihiko Nakamura, and Manabu Hirasawa. All authors attest that they meet the current ICMJE criteria for authorship.
Publisher Copyright:
© 2018 The Author(s)
PY - 2019/3
Y1 - 2019/3
N2 - Purpose: To evaluate the binocular visual function and depth of focus after staged implantation of diffractive multifocal intraocular lenses (MIOLs) with 3 different add powers following cataract removal. Design: Prospective comparative case series. Methods: Setting: Institutional. Study Population: Both eyes of 56 patients that underwent staged implantation of bifocal IOLs. Intervention: In the first eye, MIOLs with a +4.0-diopter (D) add power were implanted. Based on outcomes at 1 week postoperatively and patient preference for near vision, 1 of 3 near add powers—+4.0 D (group MM), +3.25 D (group ML), or +2.75 D (group MK)—was implanted in the fellow eye. Main Outcome Measure(s): Three months postoperatively, the binocular uncorrected and distance-corrected visual acuities (BUCVA and BDCVA, respectively) at 5.0, 1.0, 0.5, 0.4, and 0.3 meters; binocular defocus curves; contrast sensitivity; and near stereopsis were measured. Results: The MM, ML, and MK groups included 21, 18, and 17 patients, respectively. The mean BUCVA in the MM group was significantly (P =.003) worse than that in the MK group at 0.5 meter. The BDCVAs at 0.5 meter in the ML and MK groups were significantly (P <.02) better than that in the MM group. The defocus curves with the -2.0 D refraction differed significantly (P <.001) between the MM and MK groups. The binocular contrast sensitivity and stereopsis values did not differ significantly. Conclusions: Staged implantation of different add powers obtained better binocular intermediate visual acuity without degradation of visual function.
AB - Purpose: To evaluate the binocular visual function and depth of focus after staged implantation of diffractive multifocal intraocular lenses (MIOLs) with 3 different add powers following cataract removal. Design: Prospective comparative case series. Methods: Setting: Institutional. Study Population: Both eyes of 56 patients that underwent staged implantation of bifocal IOLs. Intervention: In the first eye, MIOLs with a +4.0-diopter (D) add power were implanted. Based on outcomes at 1 week postoperatively and patient preference for near vision, 1 of 3 near add powers—+4.0 D (group MM), +3.25 D (group ML), or +2.75 D (group MK)—was implanted in the fellow eye. Main Outcome Measure(s): Three months postoperatively, the binocular uncorrected and distance-corrected visual acuities (BUCVA and BDCVA, respectively) at 5.0, 1.0, 0.5, 0.4, and 0.3 meters; binocular defocus curves; contrast sensitivity; and near stereopsis were measured. Results: The MM, ML, and MK groups included 21, 18, and 17 patients, respectively. The mean BUCVA in the MM group was significantly (P =.003) worse than that in the MK group at 0.5 meter. The BDCVAs at 0.5 meter in the ML and MK groups were significantly (P <.02) better than that in the MM group. The defocus curves with the -2.0 D refraction differed significantly (P <.001) between the MM and MK groups. The binocular contrast sensitivity and stereopsis values did not differ significantly. Conclusions: Staged implantation of different add powers obtained better binocular intermediate visual acuity without degradation of visual function.
UR - http://www.scopus.com/inward/record.url?scp=85059809041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059809041&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2018.11.020
DO - 10.1016/j.ajo.2018.11.020
M3 - Article
C2 - 30552894
AN - SCOPUS:85059809041
SN - 0002-9394
VL - 199
SP - 223
EP - 229
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -